tiprankstipranks
Trending News
More News >
Liminatus Pharma (LIMN)
NASDAQ:LIMN
US Market
Advertisement

Liminatus Pharma (LIMN) Technical Analysis

Compare
53 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
3Neutral
15Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Liminatus Pharma’s (LIMN) Moving Averages Convergence Divergence (MACD) indicator is -0.35, suggesting Liminatus Pharma is a Sell.
Liminatus Pharma’s (LIMN) 20-Day exponential moving average is 1.58, while Liminatus Pharma’s (LIMN) share price is $1.15, making it a Sell.
Liminatus Pharma’s (LIMN) 50-Day exponential moving average is 2.79, while Liminatus Pharma’s (LIMN) share price is $1.15, making it a Sell.

Liminatus Pharma (LIMN) Pivot Points

Oct 20, 2025, 11:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.04
1.12
1.18
1.26
1.32
1.40
1.46
Fibonacci
1.12
1.18
1.21
1.26
1.32
1.35
1.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Liminatus Pharma (LIMN) Moving Averages

Oct 20, 2025, 11:53 PM
Period
Simple
Exponential
MA5
1.27Sell
1.27Sell
MA10
1.42Sell
1.38Sell
MA20
1.52Sell
1.58Sell
MA50
2.38Sell
2.79Sell
MA100
6.38Sell
4.76Sell
MA200
8.26Sell
7.24Sell
Liminatus Pharma’s (LIMN) 10-Day exponential moving average is 1.38, while Liminatus Pharma’s (LIMN) share price is $1.15, making it a Sell.
Liminatus Pharma’s (LIMN) 100-Day exponential moving average is 4.76, while Liminatus Pharma’s (LIMN) share price is $1.15, making it a Sell.
Liminatus Pharma’s (LIMN) stock price is $1.15 and Liminatus Pharma’s (LIMN) 50-day simple moving average is 2.38, creating a Sell signal.
Liminatus Pharma’s (LIMN) stock price is $1.15 and Liminatus Pharma’s (LIMN) 100-day simple moving average is 6.38, creating a Sell signal.
Liminatus Pharma’s (LIMN) stock price is $1.15 and Liminatus Pharma’s (LIMN) 200-day simple moving average is 8.26, creating a Sell signal.

Liminatus Pharma (LIMN) Technical Indicators

Oct 20, 2025, 11:53 PM
Name
Value
Implied Action
RSI (14)
30.96
Neutral
STOCH (9,6)
10.26
Buy
STOCHRSI (14)
7.29
Buy
MACD (12,26)
-0.35
Sell
ADX (14)
25.48
Neutral
Williams %R
-95.92
Buy
CCI (14)
-150.39
Buy
ATR (14)
0.25
-
Ultimate Oscillator
32.92
Neutral
ROC
-31.14
Sell
Liminatus Pharma’s (LIMN) Relative Strength Index (RSI) is 30.96, creating a Neutral signal.
Liminatus Pharma’s (LIMN) Trend Strength Indicator (ADX) is 25.48, creating a Neutral signal.
Liminatus Pharma’s (LIMN) Commodity Channel Index (CCI) is -150.39, creating a Buy signal.
Liminatus Pharma’s (LIMN) Price Rate of Change (ROC) is -31.14, creating a Sell signal.

FAQ

Is LIMN a Buy, Hold, or Sell?
Based on LIMN’s technical indicators, LIMN is a Strong Sell.
    What is LIMN’s RSI (14)?
    LIMN’s RSI (14) is 30.96, which suggests LIMN is a Neutral.
      What is LIMN’s MACD?
      LIMN’s MACD is -0.35, which suggests LIMN is a Sell.
        What is LIMN’s 5-day moving average?
        LIMN’s 5-day moving average is 1.27, which suggests LIMN is a Sell.
          What is LIMN’s 20-day moving average?
          LIMN 20-day moving average is 1.52, which suggests LIMN is a Sell.
            What is LIMN’s 50-day moving average?
            LIMN’s 50-day moving average is 2.38, which suggests LIMN is a Sell.
              What is LIMN’s 200-day moving average?
              LIMN’s 200-day moving average is 8.26, which suggests LIMN is a Sell.
                What is LIMN’s Williams % R (14)?
                LIMN’s Williams % R (14) is -95.92, which suggests LIMN is a Buy.
                  What is LIMN’s CCI (14)?
                  LIMN’s CCI (14) is -150.39, which suggests LIMN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis